Mideast healthcare providers show keen interest in Qvintip

Healthcare providers and public healthcare authorities participating in the Arab Health Exhibition in Dubai from 25 to 28 January showed keen interest in the Qvintip self-sampling HPV test for cervical cancer and all 14 high-risk HPV strains. An estimated 90 million women in the Middle East & North Africa (MENA) region are vulnerable to HPV…

Aprovix starts a roll-out in Pakistan!

We are happy to announce that we have secured a first pilot in Pakistan including 1,000 women for HPV testing to be escalated to 5,000 per month in the coming months.

Eurogin 2015

Aprovix will present at Eurogin 2015 in Seville, Spain on February 4-7th. Please see us at our booth 23!

Arab Health 2015

Aprovix is participating at Arab Health conference in Dubai on January 26-29th.

Repeat hrHPV testing using Qvintip

self collection at home is cost-effective in the cervical cancer prevention program. Reference: Östensson et al, Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program, Acta Obstet Gynecol Scand, 2013 Aug,92(8):994

The Swedish Board of Health and Welfare

now recommends HPV testing. From age 30 women should be offered HPV analysis insted of pap smear/cytologi. This is suggested by the Swedish Board of Health, (Socialstyrelsen)j in a new recommendation for the Swedeish screening program. Read more below, (Swedish)

Qvintip now available in Finland

Now Qvintip is available in Finland: HPV-testillämme voit selvittää kohdunkaulasyöpäriskin jo varhaisessa vaiheessa. – Etusivu

Qvintip in New York

Second year in a row Qvintip and Aprovix was invited to attend the UNGA, (United Nations General Assembly) by Princess Nikki’s Breast & Cervical Cancer Foundation with several African First Ladies participating, to present the Qvintip solution.

Reproductive Potential of Russia.

Aprovix participated in the conference September 6th – 9th, 2014. The Qvintip solution was presented to the leading Professors of the Russian Federation by CEO Lana Obolenskaja.